Gluconeogenesis is one of those Step 1 topics that feels “simple” until you get hit with a vignette about fasting hypoglycemia, lactic acidosis, and a baby who crashes after skipping one meal. The key is to stop thinking of it as “just making glucose” and start thinking like the body: Where am I? (liver vs muscle), what’s my fuel state? (fed vs fasted), what substrates do I have? (lactate, alanine, glycerol), and which enzyme is the bottleneck? This post is a high-yield, enzyme-centered deep dive with the clinical hooks you’ll actually get tested on.
What is gluconeogenesis (and when do you use it)?
Gluconeogenesis = synthesis of glucose from non-carbohydrate precursors, primarily to maintain blood glucose for:
- RBCs (no mitochondria → must use glycolysis)
- Brain (initially glucose-dependent; later adapts to ketones in prolonged fasting)
- Renal medulla and other glucose-dependent tissues
Where does it happen?
- Liver = main site
- Kidney (renal cortex) = increasingly important in prolonged fasting
- NOT skeletal muscle as a net glucose exporter (muscle lacks glucose-6-phosphatase)
First Aid cross-reference: Biochemistry → Gluconeogenesis; Regulation of glycolysis/gluconeogenesis; Metabolic states (fed/fasted); Alcohol metabolism; Fructose/galactose pathways (hypoglycemia associations).
The “Big Idea”: Gluconeogenesis bypasses the irreversible glycolysis steps
Glycolysis has 3 irreversible steps (hexokinase/glucokinase, PFK-1, pyruvate kinase). Gluconeogenesis uses 4 key enzymes to bypass these.
High-yield bypass map (know this cold)
| Glycolysis (irreversible) | Gluconeogenesis bypass enzyme | Location | Key regulator(s) | Classic Step-style clinical hook |
|---|---|---|---|---|
| Hexokinase / Glucokinase: Glucose → G6P | Glucose-6-phosphatase: G6P → Glucose | ER lumen (liver, kidney) | Substrate-driven; expression increases with fasting | Von Gierke (G6Pase deficiency): severe fasting hypoglycemia, ↑ lactate, ↑ uric acid, ↑ TG |
| PFK-1: F6P → F1,6BP | Fructose-1,6-bisphosphatase (FBPase-1): F1,6BP → F6P | Cytosol | Inhibited by AMP, F2,6BP; activated by citrate | FBPase-1 deficiency: fasting hypoglycemia + lactic acidosis/ketosis |
| Pyruvate kinase: PEP → Pyruvate | Pyruvate carboxylase: Pyruvate → OAA | Mitochondria | Activated by acetyl-CoA; requires biotin | Biotin deficiency → impaired gluconeogenesis; pyruvate carboxylase deficiency → lactic acidosis |
| (bypass continues) | PEP carboxykinase (PEPCK): OAA → PEP | Cytosol (and mito in some tissues) | Induced by glucagon, cortisol; needs GTP | High-yield: fasting hormones upregulate PEPCK; chronic steroids ↑ gluconeogenesis |
The 4 key enzymes (Step 1 deep dive)
1) Pyruvate carboxylase (mitochondria)
Reaction: pyruvate → oxaloacetate (OAA)
- Requires biotin (B7) as a CO₂ carrier
- Activated by acetyl-CoA (this is a huge “fed vs fasted” clue)
Why the acetyl-CoA activation matters:
- In fasting, fatty acid β-oxidation → ↑ acetyl-CoA
- That acetyl-CoA says: “We have energy; divert pyruvate away from TCA entry and toward glucose production.”
Clinical tie-ins
- Biotin deficiency (think: raw egg whites/avidin, prolonged antibiotics) → decreased pyruvate carboxylase activity
- Pyruvate carboxylase deficiency (rare but testable): inability to replenish OAA → ↑ pyruvate → ↑ lactate → lactic acidosis, neurologic issues
High-yield pearl: If OAA can’t be made, the liver can’t run gluconeogenesis effectively and also struggles to keep TCA intermediates replenished (anaplerosis problem).
2) PEP carboxykinase (PEPCK)
Reaction: OAA → phosphoenolpyruvate (PEP)
- Uses GTP
- Often cytosolic for Step-level conceptualization (some mitochondrial isoform exists)
Regulation (testable):
- Glucagon increases transcription (via cAMP)
- Cortisol increases transcription (steroid-induced hyperglycemia)
Step-style association:
- Patients on chronic glucocorticoids → hyperglycemia partly due to ↑ gluconeogenesis (PEPCK induction)
3) Fructose-1,6-bisphosphatase (FBPase-1) — the “rate-limiting enzyme”
Reaction: F1,6BP → F6P
This is classically considered the rate-limiting step of gluconeogenesis.
Regulation (very high-yield):
- Inhibited by AMP (low energy → don’t spend ATP making glucose)
- Inhibited by fructose-2,6-bisphosphate (F2,6BP) (fed state signal)
- Activated by citrate (energy abundant)
Clinical: FBPase deficiency
- Presentation: fasting intolerance, hypoglycemia, vomiting, hyperventilation (acidosis), possible seizures
- Labs: lactic acidosis, ketosis (because fasting drives lipolysis/ketones while gluconeogenesis is impaired)
- Management: avoid prolonged fasting; provide carbohydrates during illness; sometimes uncooked cornstarch overnight in kids
First Aid cross-reference: Regulation by F2,6BP; glucagon effect on PFK-2/FBPase-2.
4) Glucose-6-phosphatase
Reaction: G6P → glucose
Location: ER lumen (a favorite detail for Step 1)
Tissue distribution:
- Liver and kidney have it → can export glucose
- Skeletal muscle does not → muscle uses G6P locally for glycolysis/glycogen, cannot raise blood glucose directly
Clinical: Von Gierke disease (GSD I)
- Defect: glucose-6-phosphatase (or transporter to ER in some variants)
- Presentation: severe fasting hypoglycemia, hepatomegaly, failure to thrive
- Labs (classic trio):
- ↑ lactic acid (shunting to lactate)
- ↑ uric acid (lactate competes for renal excretion + increased nucleotide turnover)
- ↑ triglycerides (excess acetyl-CoA → lipogenesis)
- Treatment: frequent feeds, uncooked cornstarch, avoid fructose/galactose (both feed into G6P and worsen metabolite buildup)
First Aid cross-reference: Glycogen storage diseases table; ER enzyme localization.
Substrates: what feeds gluconeogenesis?
Major substrates (know the big three):
- Lactate (Cori cycle)
- Alanine (glucose-alanine cycle; muscle proteolysis → alanine to liver)
- Glycerol (from adipose lipolysis → DHAP)
Important negative:
- Even-chain fatty acids cannot become glucose (they become acetyl-CoA, which cannot net-convert to glucose)
- Odd-chain fatty acids → propionyl-CoA → succinyl-CoA → can contribute to gluconeogenesis (Step 1 favorite exception)
Energetics: it costs ATP (and that’s the point)
To make glucose from pyruvate, the body spends energy:
- Gluconeogenesis consumes: ATP + GTP + NADH per glucose (from 2 pyruvate)
High-yield implication:
- During fasting, energy comes from β-oxidation; that energy “pays” for gluconeogenesis.
Regulation: the hormone logic (and F2,6BP is the switch)
Glucagon vs insulin
- Glucagon (fasting) → promotes gluconeogenesis and glycogenolysis
- Insulin (fed) → promotes glycolysis and glycogen synthesis
The F2,6BP “toggle”
F2,6BP is a potent allosteric regulator:
- ↑ F2,6BP → activates PFK-1 (glycolysis ON) and inhibits FBPase-1 (gluconeogenesis OFF)
- ↓ F2,6BP → glycolysis OFF, gluconeogenesis ON
Glucagon in the liver:
- activates PKA → phosphorylates PFK-2/FBPase-2 (the bifunctional enzyme)
- net effect in liver: ↓ F2,6BP → favors gluconeogenesis
First Aid cross-reference: PFK-2/FBPase-2 regulation; glucagon signaling via cAMP.
Pathophysiology & classic clinical traps
1) Alcohol-induced hypoglycemia (super high-yield)
Ethanol metabolism increases NADH in liver:
- ethanol → acetaldehyde (ADH) → acetate (ALDH)
- both steps generate NADH
- ↑ NADH shifts:
- pyruvate → lactate
- OAA → malate
Net effect: gluconeogenesis is inhibited (substrates get trapped as lactate/malate) → fasting hypoglycemia, especially in malnourished patients.
Presentation: intoxicated patient, poor oral intake, diaphoresis, confusion; may have lactic acidosis.
First Aid cross-reference: Alcohol metabolism; NADH effects; fasting hypoglycemia differential.
2) Enzyme deficiencies: how they present
A quick, vignette-ready way to think about it:
- If you can’t do gluconeogenesis → you crash during fasting/illness
- Hypoglycemia is common
- Counter-regulation increases lipolysis → often ketosis
- Depending on the block, you can get lactic acidosis (pyruvate shunted to lactate)
Diagnosis (USMLE-style approach)
You’re rarely “diagnosing” with a single test on Step—you’re identifying patterns.
Pattern recognition table
| Scenario | Key clue(s) | Most likely issue |
|---|---|---|
| Fasting hypoglycemia + hepatomegaly + ↑ lactate + ↑ uric acid + ↑ TG | Infant/child, doll-like face | Von Gierke (G6Pase deficiency) |
| Fasting intolerance + lactic acidosis + ketosis but no massive hepatomegaly pattern like Von Gierke | episodic decompensation | FBPase-1 deficiency |
| Hypoglycemia after binge drinking + poor intake + lactic acidosis | “weekend bender” vignette | Alcohol inhibits gluconeogenesis (↑ NADH) |
| Neurologic issues + lactic acidosis; biotin-related | antibiotics, raw eggs | Pyruvate carboxylase impairment / biotin deficiency |
Treatment principles (what Step expects)
Acute management (symptomatic hypoglycemia)
- Give glucose (IV dextrose if severe)
- Treat seizures if present
- Address precipitating illness/fasting state
Chronic/definitive strategies (depends on cause)
- Avoid prolonged fasting
- Frequent complex carbohydrates
- Uncooked cornstarch overnight (common board-relevant intervention in glycogen storage disorders)
- Von Gierke: avoid fructose and galactose (they funnel into G6P and worsen metabolite accumulation)
High-yield Step 1 “don’t miss” bullets
- Rate-limiting enzyme of gluconeogenesis: Fructose-1,6-bisphosphatase
- Muscle can’t release free glucose because it lacks glucose-6-phosphatase
- Glucagon decreases F2,6BP in liver → turns gluconeogenesis ON
- Acetyl-CoA activates pyruvate carboxylase (fasting physiology: β-oxidation supports gluconeogenesis)
- Alcohol increases NADH → pushes pyruvate → lactate and OAA → malate → inhibits gluconeogenesis → hypoglycemia
- Even-chain fatty acids cannot make glucose (odd-chain exception via succinyl-CoA)
Rapid review: the four enzymes in one box
- Pyruvate carboxylase (biotin, mito): pyruvate → OAA (activated by acetyl-CoA)
- PEPCK (GTP): OAA → PEP (upregulated by glucagon/cortisol)
- FBPase-1 (rate-limiting): F1,6BP → F6P (inhibited by AMP and F2,6BP)
- Glucose-6-phosphatase (ER; liver/kidney): G6P → glucose (Von Gierke when deficient)